SUPDENO 60MG INJECTION

Form: Injection

Pack Size: 1 PFS

Marketed by: MANKIND PHARMA LTD (ONCOLOGY DIV)

MRP: ₹7116.60

MANKIND PHARMA LTD (ONCOLOGY DIV): Supdeno 60MG Injection, 1 PFS, salt denosumab 60mg. NPPA has revised its MRP from Rs 16,401.55 to Rs 7,116.60 (57% lower) with effect from 09-11-2026; trade rate Rs 5,422.17. Group: RANKL-blocking monoclonal antibody (bone-targeted therapy). Same salt is also supplied by Abbott, Cipla, Corona Remedies, Dr. Reddy's, Emcure and others. Handling/counselling: 6-monthly pre-filled syringe; do not delay or stop without the doctor - bone loss can rebound; store at 2-8 C. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.